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Summary
Background: Intra-abdominal infection in secondary pe ri -
tonitis drives as excessive production of inflammatory me -
diators and the development of systemic inflammatory res -
ponse syndrome (SIRS) or sepsis. Finding a specific marker
to distinguish SIRS from sepsis would be of immense clini-
cal importance for the therapeutic approach. It is assumed
that high-mobility group box 1 protein (HMGB1) could be
such a marker. In this study, we examined the time course
changes in the blood levels of HMGB1, C-reactive protein
(CRP), procalcitonin (PCT) and serum amyloid A (SAA) in
patients with secondary peritonitis who developed SIRS or
sepsis.
Methods: In our study, we evaluated 100 patients with dif-
fuse secondary peritonitis who developed SIRS or sepsis
(SIRS and SEPSIS group) and 30 patients with inguinal her-
nia as a control group. Serum levels of HMGB1, CRP, PCT,
and SAA were determined on admission in all the patients,
and monitored daily in patients with peritonitis until dis-
charge from hospital.
Kratak sadr`aj
Uvod: Intraabdominalna infekcija u sekundarnom peritoni-
tisu dovodi do prekomernog stvaranja inflamatornih medi-
jatora i razvoja sistemskog inflamatornog odgovora (SIRS)
ili sepse. Pronala`enje specifi~nog markera za razlikovanje
SIRS-a od sepse bilo bi od ogromnog klini~kog zna~aja za
terapijski pristup. Pretpostavlja se da bi high-mobility group
box 1 protein (HMGB1) mogao da bude takav marker. U
ovoj studiji smo ispitivali promenu nivoa u krvi HMGB1, C-
reaktivnog proteina (CRP), prokalcitonina (PCT) i serum-
skog proteina amiloid A (SAA) kroz vreme kod pacijenata
sa sekundar nim peritonitisom koji su razvili SIRS ili sepsu.
Metode: U ovoj studiji smo ispitivali 100 pacijenata sa
difuznim sekundarnim peritonitisom koji su razvili SIRS ili
sepsu (grupa SIRS i grupa SEPSA) i 30 pacijenata sa pre-
ponskim kilama koji su bili kontrolna grupa. Svim pa ci -
jentima su odre|ivane vrednosti HMGB1, CRP, PCT, SAA u
serumu na prijemu u bolnicu, dok je u grupi sa peritoniti-
som nastavljeno postoperativno merenje ovih parametara
svakog dana do otpusta iz bolnice.
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Introduction
Abdominal sepsis is a medical problem that is
associated with significant morbidity and mortality
(1). Peritonitis is one of the most important sources of
abdominal sepsis (2). The outcome of peritonitis de -
pends on systemic and peritoneal response, along
with the quantity, nature and duration of the presence
of pathogens in the peritoneal cavity (3). In a systemic
bacterial infection, the intense reaction results in
excessive formation of inflammatory mediators and
development of the systemic inflammatory response
syndrome (SIRS) (4). Secondary peritonitis is a surgi-
cal condition that requires immediate treatment.
Sepsis remains a major problem in the postoperative
period. Re-intervention in proven abdominal septic
foci significantly contributes to increased survival rate
(2). However, repeated surgical procedures are an
additional risk factor for patients. Hence, there is
great interest in finding optimal diagnostic markers
for early, noninvasive and reliable diagnosis of
abdominal infections and sepsis (2).
The most frequently determined serological
marker among the acute phase proteins important in
the diagnosis of systemic response is C-reactive pro-
tein (CRP). CRP synthesis is stimulated by cytokines
(5, 6). In an inflammatory disease, the level may be
increased as soon as in 6–8 hours, reaching a peak
after about 48 hours (5, 7, 8). Procalcitonin (PCT), a
prohormone of calcitonin (9), was found to be
increased in severe bacterial infections and sepsis
(10). It is assumed that the activation of monocytes
leads to the initial release of PCT. Subsequently, acti-
vated monocytes stimulate human adipocytes to
release PCT (11). Depending on the toxic stimulus,
an increase of the PCT concentrations in plasma
occurs within 2–6 hours (12, 13). Serum amyloid A
(SAA) is released from hepatocytes stimulated by
proinflammatory mediators along with other acute
phase proteins (14), but also from the resident
macrophages (15). During endotoxemia in humans,
SAA was consistently found to be one of the rapidly
induced acute phase proteins, reaching a peak after
14–16 hours (16, 17).
High-mobility group box 1 protein (HMGB1) is
known as »alarmin« – a molecule released during cel-
lular necrosis. Immune cells secrete it, and it is be -
lieved to be of importance in maintaining homeosta-
sis as well (18). There are two mechanisms of release
of this protein: passive release from the necrotic cells
(initiating inflammation) and active secretion from
macrophages (maintenance of inflammation) (19). It
is important to highlight that the kinetics of HMGB1
release is biphasic (20). Excessive levels of HMGB1
result in an uncontrolled inflammatory response, tis-
sue damage and organ dysfunction. Sepsis is a con-
dition that is primarily characterized by the presence
of high concentrations of serum HMGB1. HMGB1
occurs after 8–72 hours, and it is therefore desig -
nated as a »late« inflammatory mediator. Thus, it is
assumed that HMGB1 might be a potent marker and
a therapeutic target in sepsis.
The aim of this study was to assess the potential
of HMGB1, CRP, PCT, and SAA to differentiate sepsis
from noninfectious SIRS in secondary peritonitis.
Materials and Methods
Patients
The study was performed at the Clinic for Emer -
gency Surgery of the Emergency Center, Clinical
Center of Serbia in the period from September 2012
to September 2015. This prospective study included
130 patients. The study was approved by the Ethics
Committee of the School of Medicine, University of
Belgrade (No. 29/V-5).
In the study group, 100 patients (18 to 70 years
old) with signs of acute abdomen due to peritonitis of
different etiologies were included:
a. pathological perforation of the stomach and
duodenum (longer than 12 hours), gallblad-
der, appendectomy, small intestine and colon
b. inflammatory diseases of the gastrointestinal
tract
c. vascular bowel disease.
Results: Preoperative HMGB1, CRP, PCT and SAA levels were
statistically highly significantly increased in patients with
pe ritonitis compared to patients with inguinal hernia, and
significantly higher in patients with sepsis compared to
those with SIRS. All four inflammatory markers changed
significantly during the follow-up. It is interesting that the
patterns of change of HMGB1 and SAA over time were dis-
tinctive for SIRS and SEPSIS groups.
Conclusions: HMGB1 and SAA temporal patterns might be
useful in distinguishing sepsis from noninfectious SIRS in
secondary peritonitis.
Keywords: HMGB1, inflammation markers, secondary
peritonitis, sepsis, systemic inflammatory response syn-
drome
Rezultati: Preoperativne vrednosti HMGB1, CRP, PCT, SAA
bile su statisti~ki zna~ajno vi{e kod pacijenata sa peritoniti-
som u odnosu na pacijente sa ingvinalnim kilama, i sta-
tisti~ki zna~ajno vi{e kod pacijenata sa sepsom u odnosu na
one sa SIRS-om. Sva ~etiri markera inflamacije su se
zna~ajno menjala tokom vremena pra}enja. Za nim ljivo je
da su obrasci promena tokom vremena za HMGB1 i SAA
bili karakteristi~ni za grupe SIRS i SEPSA.
Zaklju~ak: Vremenski obrasci nivoa HMGB1 i SAA mogli bi
da budu korisni u razlikovanju sepse i SIRS-a bez infekcije
u sekundarnom peritonitisu.
Klju~ne re~i: HMGB1, inflamatorni markeri, sekundarni
peritonitis, sepsa, sistemski inflamatorni odgovor
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The diagnosis of sepsis/SIRS was established by
the presence of at least two of the following clinical
manifestations: fever > 38 or < 36 °C; heart rate >
90/min; respiratory rate > 20/min or PaCO2 < 4.3
kPa; white blood cell count > 12,000 or < 4,000 per
mL, or the presence of > 10% of immature neu-
trophils. The criterion defining abdominal sepsis was
the presence of an abdominal source of infection with
positive microbiological culture from the peritoneal
cavity. Patients with negative cultures were classified
as SIRS, while those with proven abdominal infections
were classified as SEPSIS group.
The control group included 30 patients (18 to
70 years old), operated for inguinal hernia without
present infection and inflammation. 
Exclusion criteria in this study were: pregnancy,
puerperium, diabetes mellitus, malignant diseases,
patients with signs of acute pancreatitis, patients on
cytostatic agents or immunosuppressive therapy,
patients infected with hepatitis B and C viruses and
the HIV, and patients with psychosis. Patients with
suspected extra-abdominal origin of infection were
also excluded from the study.
ASA score was determined preoperatively and
APACHE II score was determined on the first postop-
erative day in all the patients. ASA score ranged from
1 to 5 and APACHE II score ranged from 5 to 14.
Surgical technique
In the patients with secondary peritonitis, sever-
al types of surgery were undertaken. The most used
was the suture of duodenum, small bowel and colon
by single suture, stomach and sigmoid colon resec-
tion. Furthermore, stoma of small bowel or colon,
cholecistectomy, appendectomy and total colectomy
were performed. All patients were subjected to mid-
line incision, peritoneal lavage with 3–4 L of saline
with drain of both subphrenic space, subhepatic
space and Douglas space. In all the patients,
abdomen was closed by primary suture. Control
group underwent Linchenstein hernioplasty of
inguinal hernia.
Sampling and measurements
Blood samples were collected prior to surgery
and every day afterwards into Vacutainer tubes (BD
Vacutainer Systems, Franklin Lakes, New Jersey) with
potassium EDTA as anticoagulant for determination
of blood cell counts (Wbc, Rbc, Hgb, Hct, Plt), citrate
EDTA as anticoagulant for determination of hemosta-
sis parameters (PT, aPTT, fibrinogen, antithrombin III,
plasminogen, D-dimer). Blood cell counts were deter-
mined with an HmXanalyser (Beckman Coulter, USA)
using commercial reagents. Commercial tests
(Siemens Healthcare GmbH, Marburg, Germany)
were used for determination of hemostasis parame-
ters on BCS XP coagulation analyzers (Siemens
Healthcare GmbH, Marburg, Germany). Blood sam-
ples for routine biochemical tests determination
(gluco se, urea, creatinine, bilirubin, total proteins,
albumin, Na+, K+, Cl-, Ca2+, aspartate-amino trans -
ferase, alanine-aminotransferase, alkaline phos-
phatase, alpha amylase), and C-reactive protein, SAA
and PCT determination were allowed to coagulate at
room temperature for 30 minutes and then cen-
trifuged at 2680 g for 10 minutes to obtain serum
samples (21). Serum routine biochemical parame-
ters, C-reactive protein and PCT were measured
using the commercial assay on a Roche Cobas 6000
automated analyzer (Roche Diagnostics, Mannheim,
Ger many). SAA concentration was measured by the
particle-enhan ced immunonephelometric test
(Siemens Healthcare GmbH, Germany) on a BNII
System (Siemens Health care GmbH, Germany).
Microbiology cultures
The patients’ samples (peritoneal swab) that
had been taken during surgical procedure were sent
to a routine microbiology laboratory and were
processed, cultivated and reported according to the
standard protocols.
Western blot
Western blot to determine the HMGB1 in sera
was done as previously described (22). Briefly, 1 mL of
serum proteins was separated by SDS-PAGE on 12%
polyacrylamide gels. Upon protein transfer to a poly -
vi nylidene difluoride membrane (Hybond-P, RPN303F,
Amersham Pharmacia Biotech), the membranes were
incubated with primary anti-HMGB1 antibody (K-12,
Santa Cruz Biotechnology – dilution 1:750) and horse
radish peroxidase-conjugated bovine anti-goat sec-
ondary antibody (sc-2379; Santa Cruz Biotechnology,
Santa Cruz, CA, USA). Specific protein bands were
visualized using Western Blotting Chemiluminescence
Luminol Reagent (sc-2048, Santa Cruz Bio techno -
logy) and Hyperfilm ECL (RPN 3103 K, Santa Cruz
Biotechnology). HMGB1 quantification was perfor -
med in TotalLab v1.1 (Phoretix).
Statistical analysis
All the parameters were described in terms of
mean and standard deviation, or median and IQR,
where appropriate. The shape of variable distributions
was evaluated by Kolmogorov-Smirnov test and para-
metric or nonparametric test were applied according-
ly. The statistical significance of initial differences
between HERNIA, SEPSIS and SIRS patients was eval-
uated with chi-square test, Fisher exact test, t-test or
Wilcoxon test for unrelated samples. The temporal
patterns of selected serum parameters were analyzed
by linear mixed effect models. For the linear mixed
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effect model, in order to satisfy the assumption of nor-
mality, the non-normal variables were log-transformed
prior to entering. P values were adjusted for multiple
comparisons according to Bonferroni, and p values
less than 0.05 were considered significant. All the cal-
culations and plotting were done in R 3.1.0. (23).
Results
Demographic and clinical characteristics of the
patients are summarized in Table I. There were no
statistically significant differences between patients in
SIRS and SEPIS group. The major cause of secondary
peritonitis in the SEPSIS group was perforative appen-
dicitis, while in the SIRS group it was duodenal ulcer
perforation, without a statistically significant differ-
ence in the distribution of causative conditions (Table
I). On the other hand, distribution of operative inter-
ventions was significantly different (p=0.023)
between these groups, with appendectomy being the
most frequent procedure in the SEPSIS group and
ulcer suture in the SIRS group (data not shown). All
HERNIA patients underwent herniectomy with
inguinal canal plastic. Most of the patients with sepsis
had a polymicrobial infection (40%). The most fre-
quent infectious agent in SEPSIS was E. coli, followed
by C. albicans and anaerobic bacteria (Table I).
Leukocyte counts were significantly higher in
patients with secondary peritonitis compared to those
in the HERNIA group (p<0.001), without difference
among SEPSIS and SIRS patients (Table II). Other
basic hematological parameters were similar in all
groups.
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Table I Description of SIRS, SEPSIS and HERNIA patients, causes of the secondary peritonitis and pathogens.
Demography and clinical evaluation 
parameters at admission
Peritonitis 
SEPSIS
n=55
(n=100)
SIRS
n=45
SIRS vs. SEPSIS
p value
HERNIA
n=30
Peritonitis
vs. HERNIA
p value
Age (mean±SD) 48.8±13.3 45.9±13.1 nsa 46.2±15.7 nsa
Gender (% male) 69.1% 71.1% nsb 100% nsb
Days of hospitalization 7.1±1.9 7.2±1.8 nsa 2.0±0.0 <0.001a
Arterial hypertension 30.9% 28.9% nsc 33.3% nsc
ASA median (IQR) 2 (0) 2 (0) nsc 1 (0) nsc
APACHE II median (IQR) 8 (2.5) 7 (4) nsd 4 (3) nsd
Diagnosis n (%)
Acute gangrenous perforative 
appendicitis 19 (34.5) 6 (13.3)
nsb
Acute gangrenous perforative 
cholecystitis with calculosis 2 (3.6) 3 (6.7)
Large intestine perforation 4 (7.3) 2 (4.4)
Small intestine perforation 1 (1.8) 2 (4.4)
Proximal perforation of the rectum 1 (1.8) 0 (0)
Perforative duodenal bulbar ulcer 26 (47.3) 28 (62.2)
Perforative ulcer of the pylorus and
prepyloric region 2 (3.6) 4 (8.9)
Pathogens isolated from SEPSIS patients (% of isolates)
Escherichia coli 47.3%
Candida albicans 40.0%
Anaerobic bacteria 38.2%
Pseudomonas aeruginosa 12.7%
Staphylococcus aureus 5.5%
Other pathogens (less than 5% each) 12.7%
at-test; bFisher exact test; cChi-square test; dWilcoxon test for unrelated samples; eStreptococcus spp., Proteus mirabilis,
Enterococcus spp., Klebsiella spp., Candida spp.; ns, not significant; SD, standard deviation; IQR, interquartile range
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Considering hemostasis parameters, plasmino-
gen and D-dimer were higher in SEPSIS compared to
SIRS group, while D-dimer was higher (p<0.001) in
secondary peritonitis patients compared to control
group (Table II). Other preoperative values of hemo-
stasis parameters were similar in all groups.
Blood biochemical parameters assessment
showed that glucose levels in patients with secondary
peritonitis were statistically highly significantly higher
than in controls (p<0.001), while preoperative con-
centration of sodium, total proteins and albumin were
lower (p<0.001, p=0.014 and p<0.001, respective-
ly, Table II). SIRS and SEPSIS group did not differ for
any of the biochemical parameters. 
Preoperative serum levels of CRP, PCT, SAA and
HMGB1 were statistically highly increased (p<0.001)
in patients with peritonitis compared to patients with
hernia (Table II). PCT, CRP and HMGB1 also had sta-
tistically significantly higher levels (p=0.018, p=0.010
and p<0.001, respectively) in septic patients than in
the SIRS group (Table II).
With the goal to distinguish SEPSIS from SIRS,
we evaluated the temporal patterns of hematologic,
hemostatic and biochemical parameters. A linear
mixed model showed overall statistically significant
differences between SIRS and SEPSIS groups for CRP,
SAA and HMGB1 (Table III, column SIRS vs. SEPSIS).
Specifically, it was found that all four inflammatory
markers have shown significant changes over time in
both groups (Table III, column Time). Furthermore,
SAA and HMGB1 temporal patterns were highly sig-
nificantly different between SIRS and SEPSIS patients
(Table III, column SIRS/SEPSIS × time interaction).
Although the concentrations of PCT showed a trend
of higher values in the SEPSIS group, they failed to
reach the level of statistical significance. Kinetics of
CRP, PCT, SAA and HMGB1 are presented in Figures
1–4, respectively.
Discussion
Difference in the therapeutic approach implies
differentiation of sepsis from noninfectious SIRS.
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Table II Preoperative hematologic, hemostasis, biochemical parameters with statistically significant differences between groups.
Mean ± SD deviation or median (IQR) were presented; at-test, bWilcoxon test; ns, not significant.
Parameter
Peritonitis (n=100)
SIRS vs. SEPSIS
(p value)
HERNIA
n=30
Peritonitis
vs. HERNIA
(p value)
SEPSIS
n=55
SIRS 
n=45
Wbc (109/L) 13.9±5.5 14.5±8.2 nsa 6.5±1.43 <0.001a
D-dimer (mg/L) 1.8±1.6 2.3±2.1 nsa 0.4±0.1 <0.001a
Plasminogen (% of normal) 93.9±9.3 87.8±8.3 <0.01a 106.3±6.87 <0.001a
Glucose (mmol/L) 6.8 (2.6) 6.7 (2.8) nsb 4.85 (0.775) <0.001b
Na+ (mmol/L) 137.8±3.6 138.4±4.0 nsa 140.8±1.9 <0.001a
Total proteins (g/L) 67.5±7.7 66.5±8.4 nsa 72.3±4.0 0.014
Albumin (g/L) 41.9±6.2 40.7±6.8 nsa 46.7±2.9 <0.001a
CRP (mg/L) 46 (170.65) 9.2 (19.7) 0.018b 0.8 (1.475) <0.001b
PCT (ng/L) 0.97 (0.94) 1.19 (0.55) 0.010b 0.04 (0.02) <0.001b
SAA (mg/L) 623 (919) 451 (741) nsb 2.95 (1.1) <0.001b
HMGB1 (band optical density) 161.8±27.9 137.2±26.6 <0.001a 62.7±7.3 <0.001a
Table III CRP, PCT, SAA and HMGB1 in SIRS and SEPSIS during hospitalizationa
Parameter SIRS vs. SEPSIS (p value)
Time
(p value)
SIRS/SEPSIS×Time 
(p value)
CRP (mg/L) 0.004 <0.001 ns
PCT (mg/L) ns <0.001 ns
SAA (mg/L) 0.002 <0.001 <0.001
HMGB1 (band optical density) <0.001 <0.001 0.035
aLinear mixed effect models, ns, not significant.
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Figure 1 CRP concentration during hospitalization. Line represents mean CRP concentration during hospitalization. Grey area
represents SD.
Figure 2 PCT concentration during hospitalization. Line represents mean PCT concentration during hospitalization. Grey area
represents SD. 
Figure 3 SAA concentration during hospitalization. Line represents mean SAA concentration during hospitalization. Grey area
represents SD. Brought to you by | Narodna biblioteka Srbije
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Here, we show that SAA and HMGB1 kinetics have
the potential to make such a distinction in a group of
patients with secondary peritonitis.
In our study, causes of diffuse peritonitis, demo-
graphic characteristics, ASA and APACHE II scores
were similar in patients who developed sepsis and
patients who did not. Furthermore, routine preopera-
tive hematologic, hemostatic (except plasminogen)
and biochemical analyses were not distinctive for
SIRS and SEPSIS groups, although several of them
were statistically significantly different compared to
control group. Likewise, the temporal pattern of these
parameters, measured daily throughout the follow-up
period, could not differentiate SIRS from SEPSIS.
Peritonitis is one of the most important sources of
abdominal sepsis, and in spite of modern therapeutic
approaches is accompanied by relatively high inci-
dence and mortality (2). It was reported that ASA
score correlated with the surgical characteristics of
the procedures, length of stay in the hospital, postop-
erative infections, and the overall mortality of patients
undergoing gastrointestinal tract surgery (24, 25). In
our study, there were no deaths, possibly due to sev-
eral facts: 1) exclusion criteria were restrictive (for
example, patients with diabetes and malignancy that
frequently develop complications following surgery
were excluded); 2) preoperative ASA score in both
groups was 2, indicating that our subjects had mild
systemic disease and were relatively healthy; 3)
APACHE II score on the first day p.o. in the SIRS and
SEPSIS group was comparable and low, with low
expected mortality (26); 4) the patients were relative-
ly young. All these factors might explain the favorable
outcome in patients with diffuse peritonitis. However,
in our group of patients with sepsis, polymicrobial
infection with the predominance of E. coli and anaer-
obic bacteria was the most frequent finding, similarly
to the findings of randomized studies summarized by
the Expert Panel of the Surgical Infection Society and
the Infectious Diseases Society of America (27). There -
fore, we may exclude the option that the type of infec-
tious agent contributed to the absence of mortality in
our study.
We assessed the markers of inflammation such
as CRP, PCT, SAA and HMGB1 preoperatively, and
their kinetics during the hospitalization period. In our
study, preoperative values of CRP were significantly
higher in the group with secondary peritonitis com-
pared to HERNIA group, while in SEPSIS group they
were significantly higher than in SIRS group. Similarly,
in a recent study conducted by Gucyetmez and Atalan
(28), CRP values were higher in patients with sepsis
compared to those with SIRS. Although CRP values
higher than 2 SD over reference value were suggest-
ed to be included in the diagnostic criteria for sepsis
(29), in our study this criterion could not discriminate
SIRS from SEPSIS patients. Over time, the concentra-
tion of CRP changed significantly: there was an evi-
dent increase following surgical procedure reaching
the maximum value on the second postoperative day,
and then the values would fall continuously until the
end of the hospitalization period. This pattern was
present in both SIRS and SEPSIS groups and could be
attributed to an uncomplicated recovery. Similarly,
Berger et al. (30) showed that CRP reaches a maxi-
mum after 2 p.o. days, and decreases afterwards.
Determining the CRP concentration is relatively
cheap, easily feasible and therefore suitable in the
daily routine work. However, its predictive value might
be limited for predicting presence of infection in
patients with SIRS due to the large overlap of values
in these two groups. 
Patients in SEPSIS group had higher PCT con-
centrations compared to those in SIRS group prior to
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Figure 4 HMGB1 level during hospitalization. Line represents mean HMGB1 band optical density. Grey area represents SD.
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surgery. Infection readily induces PCT, which could
explain the preoperative difference between the
examined groups (10). However, other stimuli such as
proinflammatory cytokines and tissue damage (31)
that are certainly present in patients with secondary
peritonitis may drive PCT synthesis and blunt the ini-
tial difference between patients with and without
infection. In our group of patients with secondary
peritonitis, PCT reached the maximum value on the
first p.o. day, and steadily declined afterwards, which
can be attributed to the rapid recovery of our patients.
Baykut et al. showed that the value of PCT re mained
elevated during 4 days p.o. in patients with infection
after cardiac surgery, with another jump between
days 4 and 6 p.o. In patients who did not have an
infection, elevated PCT levels begin to decrease on
day 2 p.o. (32). In studies by Novotny et al. (33) and
Jung et al. (34) on patients with peritonitis where the
trend of plasma PCT was assessed, a decrease two
days after surgical removal of the septic focus was re -
ported. 
Luzzano et al. (35) in their study involving 800
patients showed that PCT is a better marker of sepsis
than CRP. CRP was also less precise in distinguishing
SIRS from sepsis. In a meta-analysis of 33 published
studies measuring CRP and PCT values, it was con-
cluded that PCT is a good diagnostic biomarker for
the diagnosis of these conditions and that it is superi-
or in comparison to CRP (36). However, they also
highlighted that there are studies without statistically
significant differences between patients with and
without sepsis. Yang et al. (37) included 18 studies in
their meta-analysis with 1827 patients in total to
determine the potential benefit of PCT levels in the
diagnosis of bacterial peritonitis, showing relatively
good sensitivity and specificity. However, given the
methodological limitations and significant hetero-
geneity in groups, they suggested that medical deci-
sions should be made after the summation of clinical
findings and PCT levels and that PCT cannot be used
as the gold standard for diagnosis of peritonitis, alone
or with other markers (37).
Data on the temporal pattern of SAA concentra-
tion in adult patients with sepsis is scarce. We found
that preoperative SAA concentration was significantly
higher in patients with peritonitis compared to
patients with hernia. There was no difference in pre-
operative SAA concentration between the groups
SIRS and SEPSIS, but SAA levels were higher on day
1 p.o. in SEPSIS compared to SIRS, and then con -
tinuously declined until the end of hospitalization in
both groups, possibly due to the initiation of anti -
biotic therapy and elimination of infective foci. There
was a highly significant group × time interaction, i.e.
SIRS and SEPSIS had distinctive kinetics of SAA post-
operatively. Temporal pattern of SAA in our SEPSIS
group was similar to the one reported by Cicarelli et
al. in a group of survivors from septic shock (38). 
Preoperative HMGB1 levels in our group of
patients with peritonitis were increased compared to
patients with hernia, which could be explained by the
tissue destruction that occurs in peritonitis. HMGB1
levels were significantly higher in SEPSIS than in SIRS
group, probably due to an intensive inflammatory res -
ponse caused by the presence of an infectious
microorganism in the group SEPSIS. HMGB1 con-
centration was decreased in the following three days
possibly due to abundant peritoneal lavage. In
patients with sepsis, however, HMGB1 concentration
rose again probably due to its release from mononu-
clear cells activated by bacterial products.
Alternatively, a high concentration of HMGB1 may be
the result of persistence of infective or necrotic foci,
but since none of our patients required re-interven-
tion, we cannot speculate on this matter. Interestingly,
Van Zoelen et al. showed that HMGB1 release kinet-
ics depend on the source of infection, but this did not
affect the mortality and severity of the disease (39),
while Gibot et al. (40) demonstrated an association of
HMGB1 levels with the severity of septic shock.
Although HMGB1 and SAA were demonstrated
to be significant parameters for the distinction of SIRS
and sepsis, due to the patient number, this study
should be considered somewhat preliminary.
Determining them in a larger cohort would provide a
definite conclusion about their utility in routine clini-
cal practice. It is also worth noticing that the exclusion
criteria lead to a study group predisposed to recover
well. Such criteria were chosen to avoid the presum-
ably complex influence of the excluded underlying
conditions on the determined parameters. In order to
broaden the potential application of these markers,
however, they should be assessed in patients with a
variety of comorbidities. Although in our study the
SIRS and SEPSIS group did not differ in the frequen-
cy of particular diagnosis, they did differ in the fre-
quency of a certain type of surgical management, due
to several treatment modalities for each causative
condition of secondary peritonitis and, at least to
some extent, this cannot be excluded as the reason
for differences in the inflammation markers kinetics.
We are fully aware that a limitation of our study is the
fact that the diagnosis of sepsis was based on positive
intraperitoneal swabs as evidence of infection.
Nevertheless, this definition of sepsis (SIRS with pres-
ence of infection – local or systemic) (41, 42) would
most probably include a septic patients with falsely
negative blood culture and some of those who actu-
ally were not septic. Keeping this in mind, the choice
of a microbiological criterion would rather blunt the
observed differences in inflammatory marker levels
between the SIRS and SEPSIS group.
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Conclusions
Inflammatory markers HMGB1, CRP, PCT, and
SAA were significantly elevated in secondary peritoni-
tis compared to patients operated for inguinal hernia
without signs of present infection and inflammation.
Our study demonstrates higher HMGB1 release in
patients with sepsis compared to those with SIRS. As
a late marker of inflammation, HMGB1 may reflect
release of bacterial products following antibiotic treat-
ment. HMGB1 and SAA temporal patterns might be
useful in distinguishing sepsis from noninfectious
SIRS in secondary peritonitis.
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